(Reuters) -Production of Johnson & Johnson’s COVID-19 vaccine at a U.S. manufacturing plant was halted by the U.S. Food and Drug Administration while the agency
Read more
Home »
FILE PHOTO: A car drives past the sign for vaccine developer Novavax at the company’s headquarters in Gaithersburg, Maryland, November 30, 2020. REUTERS/Raphael Satter(Reuters) –
Read more
(Reuters) -The U.S. government will allocate nearly 85% fewer Johnson & Johnson COVID-19 vaccine doses to states next week, according to data from the Centers
Read more
FILE PHOTO: A healthcare worker prepares a dose of the AstraZeneca coronavirus disease (COVID-19) vaccine, as vaccinations resume after a brief pause in their use
Read more
HELSINKI (Reuters) – Finnish nurse Sari Roos is teaching her colleagues a vaccination technique that enables her to squeeze more doses out of COVID-19 vaccine
Read more
FILE PHOTO: Staff member handles AstraZeneca COVID-19 vaccines in storage at Region Hovedstaden’s Vaccine Center, Copenhagen, Denmark February 11, 2021. Ritzau Scanpix/Liselotte Sabroe via REUTERS
Read more
Britain’s Prime Minister Boris Johnson leaves Downing Street in London, Britain, March 17, 2021. REUTERS/Hannah McKayLONDON (Reuters) – Britain expects the European Union to stand
Read more
BRASILIA (Reuters) – Brazil’s health regulator Anvisa on Friday said it has given final approval for AstraZeneca Plc’s COVID-19 vaccine developed with Oxford University, which
Read more
BRUSSELS (Reuters) – AstraZeneca has again angered the EU by scaling back deliveries of COVID-19 vaccines, but got a boost on Friday when the World
Read more
Slideshow ( 2 images )ZURICH (Reuters) – Swiss drugmaker Roche said on Thursday that adding its drug Actemra to Gilead Sciences remdesivir, or Veklury, in
Read more